Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

ProAlgaZyme may decrease risk of stroke or heart attack

Jan. 22, 2004

Guilford launches marketing efforts for Aggrastat, plans PCI registration study

Jan. 22, 2004

Novel factor Xa inhibitors prepared and tested at Boehringer Ingelheim

Jan. 19, 2004

Archemix and Nuvelo enter development agreement for ARC-183

Jan. 15, 2004

Akzo Nobel to transfer Arixtra to Sanofi-Synthelabo

Jan. 13, 2004

NCX-4016 reaches primary efficacy endpoint in phase IIa PAOD study

Jan. 12, 2004

Improved profile of TRA-418 possibly due to dual activity

Jan. 5, 2004

FR-181157 shows potent PGI2 agonist activity and good pharmacokinetic profile

Dec. 30, 2003

France is first country to approve oral thrombin inhibitor

Dec. 30, 2003

The Medicines Company acquires cangrelor from AstraZeneca

Dec. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...